The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Tiziana plans switch to US; Vertu ups guidance

Fri, 20th Aug 2021 11:13

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Remote Monitored Systems PLC, up 25% at 0.75 pence, 12-month range 0.36p-5.00p. Reports new Anglo-Indian partnership between its subsidiary Pharm 2 Farm Ltd and India's VKE Enterprises to distribute its Pro-Larva mask. The London-based survey and inspection services provider says Pro-Larva mask is the first anti-viral mask to be approved by the UK Medicines & Healthcare Products Regulatory Agency as a class 1 medical device. The Pro-Larva face mask is made in Britain using patented a-Virion nanotechnology that is clinically proved to kill 99.9% of Covid and Influenza viruses, within 5 minutes of contact, and continues to kill the virus for seven hours, RMS says.

----------

Vertu Motors PLC, up 7.6% at 50.80 pence, 12-month range 24.40p-50.60p. Sees strong used vehicle gross margin retention, due to "exceptional" UK used car market conditions. As a result, expects adjusted pretax profit of no less than GBP50 million in year to August 31, upped from previous guidance between GBP40 million to GBP45 million. "The group's like-for-like new vehicle order take for the key month of September is currently running in excess of prior year levels, however, there is a risk that well documented new vehicle supply shortages will result in vehicle deliveries being delayed into future periods. As a consequence of reduced new vehicle supply, used vehicle supply may also be restricted in the coming months," company adds.

----------

AIM - LOSERS

----------

Amur Minerals Corp, down 11% at 2.18 pence, 12-month range 1.30p-2.90p. Notes permanent conditions report on its far east Russia Kun-Manie nickel copper sulfide project completed. It shows the nickel cutoff grade is calculated to be 0.3% nickel. Revenue is based on a presently conservative nickel price of USD13,300 per tonne and a copper price of USD5,960 per tonne. Metal recoveries are anticipated to be 74% for nickel and 52% for copper. Mine ore production and the nominal mill throughput at six million tonnes per annum indicates a potential mine life in the order of 25 years. The report says the reserve base is substantial and suitable to potentially sustain an 11.2 million tonne per year throughput

----------

Tiziana Life Sciences PLC, down 12% at 51.08 pence, 12-month range 51.08p-204.00p. Formally starts strategic plan to change its corporate structure by establishing Tiziana Life Sciences Ltd, a Bermuda-incorporated company, as the ultimate parent company of the Tiziana group. Shares will be swapped for shares in the new parent company, which will then be listed in the US on Nasdaq. As a result, Tiziana to be delisted in London. "The interests of its business and shareholders are best served by aligning the place of the listing with the principal business activities of the Tiziana group, which are predominately based in the US," company explains.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Jul 2016 08:46

Tiziana Life Buys Gene Samples Of Long-Lifed Sardinian Community

Read more
24 Jun 2016 09:49

WINNERS & LOSERS SUMMARY: Gold, Dollar Exposure Rewarded Post-Brexit

Read more
24 Jun 2016 07:44

UPDATE: UK Chemicals And Pharmaceuticals Must "Look To Future"

Read more
23 Jun 2016 15:08

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 08:27

Tiziana Life Sciences 2015 Loss Widens As It Progresses Candidates

Read more
1 Jun 2016 14:49

Tiziana partnership scoops innovation award

(ShareCast News) - Clinical stage biotechnology company Tiziana Life Sciences was celebrating on Wednesday, after its partnership with researchers at Cardiff University collected a fresh award. The AIM-traded company said the partnership, which has led to the development of a potential new drug for

Read more
19 May 2016 10:13

Tiziana Life Sciences Says Its Antibody Foralumab Featured In Review

Read more
4 Apr 2016 07:36

Tiziana Life Sciences Appoints Tiziano Lazzaretti As Finance Chief

Read more
4 Apr 2016 07:32

Tiziana Life Sciences appoints new CFO

(ShareCast News) - Tiziana Life Sciences has appointed Tiziano Lazzaretti as Chief Financial Officer, effective immediately. Confirming the move on Monday, the AIM-listed biotechnology company said the appointment was not a board level position. Lazzaretti has extensive experience in the healthcare

Read more
13 Jan 2016 09:53

Tiziana Life Sciences Raises Funds Via Convertible Loan Note Issue (ALLISS)

Read more
11 Jan 2016 09:17

Tiziana To Focus Foralumab Development On Two Clinical Applications

Read more
8 Jan 2016 08:35

Tiziana reveals possible new anti-cancer molecule

(ShareCast News) - Tiziana Life Sciences revealed the great strides it had made in the quest for cancer-fighting drugs this week, as part of its research partnership with the Cardiff University / Prifysgol Caerdydd. The AIM-listed biotechnology company, which focuses on targeted drugs to treat disea

Read more
8 Jan 2016 07:54

Tiziana Identifies New Potential Cancer Drug With Cardiff University

Read more
9 Dec 2015 09:20

Tiziana Life Sciences Appoints James Tripp Chief Operating Officer

Read more
8 Dec 2015 10:04

Tiziana Life Sciences Raises GBP3.8 Million Via Convertible Note Issue (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.